Search

everythinglearnresearchcommunity

for

Search:↓

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

A protein called PLC2 is important for the growth and development of plant roots influenced by auxin.

Immune cells affect hair growth and could lead to new hair loss treatments.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Using neurohormones to control keratin can lead to new skin disease treatments.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Changing light exposure can affect hair growth timing in goats, possibly due to a key gene, CSDC2.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Tissue stiffness affects hair follicle regeneration, and Twist1 is a key regulator.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.